Abstract

e17056Background: Elucidating the molecular pathways that drive progression or metastases of ovarian cancer may provide insight into prognosis and potentially treatment of advanced or recurrent ova...

Full Text

Published Version

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
RETRACTED ARTICLE: Correlation of CD44v6 expression with ovarian cancer progression and recurrence
Jun Shi ... Zhou Zhou
BMC Cancer | VOL. 13
Jun Shi, et. al.Jun Shi ... Zhou Zhou
08 Apr 2013
The value of 18F-FDG PET/CT imaging combined with detection of CA125 and HE4 in the diagnosis of recurrence and metastasis of ovarian cancer.
X-N Wang ... X-W Cui
European review for medical and pharmacological sciences | VOL. 24
X-N Wang, et. al.X-N Wang ... X-W Cui
01 Jul 2020
Abstract 241: Vimentin offers a potential target for the prevention of ovarian tumor progression and recurrence
Aparna Yellapa ... Janice M Bahr
Cancer Research | VOL. 77
Aparna Yellapa, et. al.Aparna Yellapa ... Janice M Bahr
01 Jul 2017
Targeting Gonadotropin-releasing Hormone Receptor Inhibits the Early Step of Ovarian Cancer Metastasis by Modulating Tumor-mesothelial Adhesion
Lydia Wt Cheung ... Alice St Wong
Molecular Therapy | VOL. 21
Lydia Wt Cheung, et. al.Lydia Wt Cheung ... Alice St Wong
20 Nov 2012
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Influence of Nucleophosmin ( NPM1 ) Genotypes on Outcome of Patients With AML: An AIEOP-BFM and COG-SWOG Intergroup Collaboration
Claudia Tregnago ... Martina Pigazzi
Journal of Clinical Oncology | VOL. -
Claudia Tregnago, et. al.Claudia Tregnago ... Martina Pigazzi
02 Dec 2024
Development and Validation of the RSClinN+ Tool to Predict Prognosis and Chemotherapy Benefit for Hormone Receptor–Positive, Node-Positive Breast Cancer
Lajos Pusztai ... Kevin M Kalinsky
Journal of Clinical Oncology | VOL. -
Lajos Pusztai, et. al.Lajos Pusztai ... Kevin M Kalinsky
02 Dec 2024
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O 6 -Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET)
Thomas Walter ...
Journal of Clinical Oncology | VOL. -
Thomas Walter, et. al.Thomas Walter ...
25 Nov 2024
Using Cure Models for Trial Analysis and Design
Michael L Leblanc
Journal of Clinical Oncology | VOL. -
Michael L LeblancMichael L Leblanc
25 Nov 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.